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e-mail address: lolo_opto@yahoo.com (L.S. AlKahmous).Lina S. AlKahmous a,⇑; Ahmed A. Al-Saleh bAbstractPurpose: The aim of this study was to evaluate the effectiveness of occlusion therapy in the control of intermittent exotropia (IXT)
in children between 4 and 10 years in Saudi Arabia. This study will highlight the importance of patching IXT patients and assist to
approach the proper use of occlusion therapy.
Methods: A clinical, prospective cohort pilot study was performed on 21 untreated IXT patients. Evaluation of the deviation angle,
amplitudes, stereopsis and control before, during and after occlusion therapy was performed.
Results: Eleven percent of the subjects demonstrated a decrease in the deviation angle by 50% while 55.5% attained normal
ranges for base-out fusional amplitudes and 77% attained success for the control.
Conclusion: We suggest that alternate occlusion therapy can improve the sensory status and strengthen the fusional amplitudes
but does not improve the deviation angle and therefore is useful to postpone surgery in young children and may improve surgical
outcome.
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Exotropia is an eye condition where the two eyes are not
aligned along the same axes, but instead the axes diverge.
Intermittent exotropia (IXT) is an exodeviation intermittently
controlled by fusional mechanisms and spontaneously breaks
down into a manifest exotropia. At other times the eyes are
aligned and binocular single vision is maintained.1
Treatment of exodeviations is indicated if the patient is
symptomatic and binocular function is affected. Surgical or
non-surgical treatments aim to reduce episodes of manifest
exotropia by reducing the angle of deviation and improving
control of fusion.2 The decision to perform surgery remains
a contentious issue and each case has specific indicationsincluding the age of the patient, angle of deviation, symp-
toms, cosmesis, fusion potential, history, onset, and progno-
sis. The reasons for non-surgical correction also vary,
including patients who want to avoid surgery and clinicians/-
patients who want to delay surgical intervention for clinical/
personal reasons.3 Occasionally non-surgical treatment allevi-
ates symptoms such that surgical invention is unnecessary.3
Occlusion therapy is considered an antisuppression therapy
to prevent or eliminate suppression and to induce diplopia
in some cases and therefore stimulate motor fusion. How-
ever, not all patients complain of diplopia in antisuppression
therapy.2 Part-time or full-time occlusion of the dominant
eye, or alternate occlusion in patients without ocular prefer-
ence, has been used for this therapy. In this study, wee:
al.com
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remove the suppression mechanism present under binocular
conditions and therefore stimulate and/or improve binocular-
ity by the end of treatment.
The aim of this study was to evaluate the effectiveness of
occlusion therapy in the control of IXT and the angle of devi-
ation in children between 4 and 10 years old in Saudi Arabia.
To our knowledge, occlusion therapy has not been studied
extensively in the literature and to address this gap, the
objective of the current study was to provide clear methodol-
ogy and success criteria for this type of therapy.Materials and methods
A clinical, prospective cohort pilot study was performed.
Thirty-six children were initially enrolled and 21 were able
to complete the study. The 21 children were from 4 to
10 years old and had untreated IXT. The angle of the diver-
gence and the child’s ability to control the deviation were
measured and compared before, during and after antisup-
pression (occlusion) therapy. The before and after test results
were statistically analyzed in order to assess the effectiveness
of occlusion therapy on IXT.
We included patients with diagnosed near and/or distance
IXT of at least 10 PD, age range between 4 and 10 years and
no amblyopia or history of previous ocular treatment and any
coexisting ocular pathology.
Patients’ testing was performed in a standardized manner
to minimize dissociation of the eyes. We evaluated the devi-
ation angle at distance and near, stereopsis at distance and
near, base-out fusional amplitudes at distance and near,
binocular visual acuity and the control score scale. Control
score scale was assessed by the office based scale as
described by Mohney and Holmes.4
The treatment regimen of occlusion was 50% of waking
hours which is about 6 h a day of alternate occlusion. Each
patient was assessed at four consecutive month intervals dur-
ing occlusion treatment plus reassessment after one month
without occlusion treatment.Statistical analysis
Data were analyzed using SPSS software version 17.0 and
MedCal version 8.0. Descriptive and analytical statistics were
performed. The Wilcoxon signed rank test was used to com-
pare means for successive follow-ups. General linear model
analysis of variance (ANOVA) for repeated measures was
used to determine differences between follow-up visits. A P
value less than 0.05 was considered statistically significant.Table 1. Cohort demographics and refractive error of intermittent
exotropes who underwent occlusion therapy.
Variable Mean Standard
Deviation
Min. range Max. range
Age 8.50 1.47 6.00 10.00
Age of onset 4.70 1.59 2.00 7.00
OD SE 1.25 1.30 3.80 0.37
OS SE 1.29 1.24 3.75 0.25Results
Success for the deviation was indicated by a 50% decrease
in the deviation angle at near and distance. Success for stere-
opsis at near was 40 s of arc, and for stereopsis at distance
success was 60 s of arc which are considered within the nor-
mal range. Success for base-out fusional amplitudes at near
was 35 PD and 20 PD for distance which are considered
within the normal range.5 Success for binocular visual acuity
was 0 LogMAR or better. Success for the control score scale
was a rating of 0 or 1 for the distance and near control score.Thirty-six IXT patients were enrolled in this study; fifteen
patients did not attend after the first follow-up visit and were
therefore excluded from the study. Twenty-one patients
attended all the follow-up visits; yet, three did not complete
the full duration of therapy and stopped during the second or
third follow-up visits. Eighteen patients completed the full
therapy (Table 1).
For individual deviation interpretation at distance, only
three patients achieved success where the deviation
decreased by 50% at the completion of the treatment while
two patients (11%) attained success after the treatment visit
and the success rate throughout the four follow-up visits
was 4% (1/21), 14% (3/21), 15.7% (3/19) and 11% (2/18) for
the second visit, third visit, fourth visit and fifth visit respec-
tively. Although significant changes for the deviation at dis-
tance occurred at the first visit to the fourth and the first
visit to the fifth visit, we will rely on our individual interpreta-
tion as it reflects a more detailed evaluation of our data for
every individual throughout the five visits. The statistical anal-
ysis calculated the mean value of the deviation angle for all
the patients in every visit and compared them as an average
which reduces the accuracy of the statistical findings. Accord-
ing to our individual interpretation, a low success rate was
reported for deviation measurements at distance after the
end of the treatment. However, for individual interpretation
of deviation at near, success was achieved in 44.4% of the
eighteen patients who completed the full duration of treat-
ment at their last visit (fifth visit) and there were significant
changes when comparing the first visit to the fourth visit
and the first visit to the fifth visit.
The success rate for stereopsis at distance was high start-
ing from the third visit to the last visit. The minor differences
between the third to the fifth visits in stereopsis at distance
explain lack of significance between visits. Additionally,
27.7% of the patients were within normal stereoacuity at
the outset which indicates there was little room for improve-
ment in approximately a third of the cases and therefore
this may explain the lack of statistical significance calculated
by the Wilcoxon signed rank test. However, individual inter-
pretation indicated a success rate of 94% at the last visit
where 17 cases out of eighteen improved to normal
stereoacuity. More than 50% of the subjects had normal
near stereoacuity at the first visit which left little room for
improvement and therefore warranted minor discussion or
analysis.
Base-out fusional amplitudes at distance attained success-
ful levels in 55.5% of the cases. The difference between the
first and fourth visits and first visit and fifth visit was signifi-
cant (P = 0.000, both comparisons). There were no significant
differences between other visits (P > 0.05, all comparisons).
In reviewing the data individually throughout the four
follow-up visits, results of the fusional amplitudes measures
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second follow-up visit. Sixteen out of nineteen patients had
within 5 PD changes from visit three to visit four and seven-
teen patients out of eighteen had within 5 PD changes from
visit four to visit five. This may explain the lack of significance
between these visits. Additionally, Fig. 1 plots the improve-
ment between the first follow-up visit to the second follow-
up while smaller differences occur between subsequent visits
indicating the little room for improvement at last visit. Base-
out fusional amplitude at near results improved successfully
in 94.4% of our cases. However, only the first (P = .001) and
second (P = .003) follow-ups were statistically significant.
When data were reviewed, eleven patients had within 5 PD
changes from visit three to visit four and ten patients had 5
PD changes from visit four to visit five which explains the lack
of significant change as these values were slightly more than
50% of the cases. In addition, significant improvement was
attained comparing the first visit to the fourth (P = .000)
and to the fifth (P = .001) follow-up visits.
Successful binocular visual acuity was attained in 94.4% of
our cases with significant improvement between the first visit
to the fourth visit (P = .001) and the fifth (P = .001) follow-up
visits. There was significant change in the first follow-up as
well (P = .002). Individual analysis indicates the consistency
of the data from one visit to another which explains the lack
of significance in the second (P = .221), third (P = .109) and
fourth (P = .317) follow-up visits.
Data for the control score scale at distance indicated a
77.7% success rate. Significant changes occurred between
the first visit to the fourth (P = .002) and to the fifth
(P = .015) visits. There was a significant difference in the first
(P = .006) follow-up. Individual analysis of the data indicates
the consistency of the data between the remaining follow-
up visits explaining the lack of statistical significance for the
second (P = .206), third (P = .206) and fourth (P = .257)
follow-up visits.
There was a 100% success rate for the control score scale
at near. There was a significant difference between the first
visit to the fourth (P = .003) and the fifth (P = .001) visits.
There was a significant difference in the first (P = .001) and
second (P = .046) follow-up visits as well. In the remaining
follow-up visits, consistency of the data is evident from visit
to visit when the data are individually evaluated. This consis-
tency explains the lack of significance.Figure 1. The change in success rate from one visit to the successive visit for d
at distance of intermittent exotropes who underwent occlusion therapy.Discussion
All of our variables under study indicated moderate to
high success except for the deviation angle at distance. Near
stereoacuity was excluded from this analysis as discussed
above. Our distance deviation findings are similar to those
reported by Figueira and Hing6 who treated their subjects
with occlusion therapy alone for near and distance and
reported rates of 6% (3/50), 8.57% (3/35), 5.26% (1/19) and
0% (0/5) at 6 months, 1, 2 and 5 year follow-ups, respectively,
with no significant difference. Due to the differences in the
clinical testing methods, comparison of other variables
between our study and Figueira and Hing’s study is not pos-
sible. Our results concur with Reynolds and Wackerhagen7
who reported 6% of their patients achieved a persistent
improvement in angle size. Similarly, Flynn, MeKenney and
Rosenhouse8 reported a 68% success rate for sensory and
motor effects of occlusion therapy where the fusional ranges
increased, the diplopia awareness improved and the control
of the deviation improved as well. Alternately, 39% of the
cohort in the Flynn, et al. study worsened in the size and fre-
quency of the deviation. Asbury9 found that 94% of subjects
obtained stereopsis with enhanced fusional vergence ampli-
tudes at near and distance which agrees with our findings.
Contrary to our observations, Suh et al.10 found that part-
time occlusion therapy resulted in a significant reduction of
the deviating angles at distance. However the data for near
deviation in the Suh et al. study concur with our results. Sim-
ilarly, 27% of patients in the Freeman and Isenberg11 study
became orthophoric and 45.5% had an asymptomatic
exophoria at the last examination which differs from our devi-
ation angle results at distance. Furthermore, Iacobucci and
Henderson12 showed a beneficial effect of occlusion therapy
on exodeviations, both in pattern type and size of deviation
which also disagrees with our results for deviation at dis-
tance. In addition, Spoor and Hiles13 reported an improve-
ment in 54% in the deviation angle at distance and
concluded that occlusion therapy decreases the size of the
deviation. However, Berg, Lozano and Isenberg14 found that
occlusion therapy decreases deviation angle at near (77%)
and distance (56%). Newman and Mazow15 found that 87%
of their subjects who were treated with occlusion therapy
reported decrease in the deviation size or converted to pho-
ria which differs from our findings.eviation at distance, distance stereopsis and base-out fusional amplitudes
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results. Other studies however used different methodology
than ours and compared occlusion therapy to other treat-
ment modalities. Cooper and Leyman16 found that occlusion
therapy is useful in breaking down suppression with 63% of
the cohort who were treated with occlusion therapy showing
fair to good results for deviation angle, stereopsis and
fusional amplitudes which partially agrees with our results in
the stereopsis and fusional amplitudes part only. Chutter17
found that the size of the deviation decreased after treat-
ment application which differs from our findings but the
fusional ranges were improved and the fusional recovery
(control) was strengthened which is similar to our findings.
We aimed at the end of our research to answer the follow-
ing questions:
1. Does antisuppression therapy improve control in non-
diplopic patients with intermittent exotropia?
2. Are the benefits of treatment stable one month after ces-
sation of treatment?
Conclusion
In conclusion, this prospective pilot study of IXT patients
treated with alternate antisuppression occlusion therapy sug-
gests that alternate occlusion therapy can improve the sen-
sory status and strengthen the fusional amplitudes at near
and distance. In addition, we suggest that occlusion therapy
can improve the deviation control but does not improve the
size of the angle of deviation although it does not worsen it.
At the end of our study we can answer the Study question 1.
Does antisuppression therapy improve control in non-
diplopic patients with intermittent exotropia? Yes, but not
the size of deviation. Study question 2. Are the benefits of
treatment stable one month after cessation of treatment?
Improved success rates occurred over consecutive visits for
fusional amplitudes, stereopsis and deviation control and
final levels were maintained at one month after final therapy
except for the angle of deviation.
Ethical compliance statement
This project has been approved by the Dalhousie
University ethical committee and King Khaled Eye Specialist
Hospital ethical committee and subjects signed an informed
consent to their participation in this study.
Financial support
No financial support was involved in this research.Conflict of interest
The authors declared that there is no conflict of interest.
Acknowledgments
Thanks are extended to the faculty of the Clinical Vision
Science Program at Dalhousie University, Halifax, Canada,
for the ongoing motivation given and for building up the
skills academically and clinically; and to the colleagues and
mentors at the King Khaled Eye Specialist Hospital, Riyadh,
Saudi Arabia. A note of thanks is also extended to my
beloved family for always being by my side.
References
1. Ansons AM, Davis H. ExotropiaDiagnosis and management of ocular
motility disorders. Oxford: Blackwell; 2001.
2. Von Noorden GK, Campos EC. Exodeviations. In: von Noorden GK,
editor. Binocular vision and ocular motility: theory and management
of strabismus. St. Louis: Mosby; 2002. p. 356–76.
3. Karlsson V. Does nonsurgical treatment of exodeviation work? Am
Orthoptic J 2009;59:18–24.
4. Mohney BG, Holmes JM. An office based scale for assessing control
in intermittent exotropia. Strabismus 2006;14:147–50.
5. Wright KW, Spigel PH. Binocular vision and introduction to
strabismus. In: Wright KW, editor. Pediatric ophthalmology and
strabismus. New York: Springer; 2003. p. 154155.
6. Figueira EC, Hing S. Intermittent exotropia: comparison of
treatments. Clin Exp Ophthalmol 2006;34:245–51.
7. Reynolds JD, Waackerhagen M. Early onset exodeviations. Am
Orthoptic J 1988;38:94–100.
8. Flynn JT, MeKenney S, Rosenhouse M. Management of intermittent
exotropia. In: Moor S, Mein J, Stockbridge L, editors. Orthoptics:
past, present, future. Chicago: Medical Publishers; 1976. p. 551–7.
9. Asbury T. The role of orthoptics in the evaluation and treatment of
intermittent exotropia. In: Arruga A, editor. International strabismus
symposium. New York: Karger; 1968. p. 331–8.
10. Suh YW, Kim SH, Lee JY, Cho YA. Conversion of intermittent
exotropia types subsequent to part-time occlusion therapy and its
sustainability. Von Graefe’s Arch Clin Exp Ophthalmol
2006;244:705–8.
11. Freeman RS, Isenberg SJ. The use of part-time occlusion for early
onset unilateral exotropia. J Pediatr Ophthalmol Strabismus
1989;26:94–6.
12. Iacobucci I, Henderson JW. Occlusion in the preoperative treatment
of exodeviations. Am Orthoptic J 1965;15:42–7.
13. Spoor DK, Hiles DA. Occlusion therapy for exodeviations occurring in
infants and young children. Ophthalmology 1979;86:2152–7.
14. Berg PH, Lozano MJ, Isenberg SJ. Long term results of part time
occlusion for intermittent exotropia. Am Orthoptic J 1998;48:85–9.
15. Newman J, Mazow ML. Intermittent exotropia. Arch Ophthalmol
1956;55:484487.
16. Cooper J, Medow N. Intermittent exotropia, basic and divergence
excess type. Binocular Vision Eye Muscle Surgery 1993;8:185–216.
17. Chutter C. Occlusion treatment of intermittent divergent strabismus.
Am Orthoptic J 1977;27:61–7.
